Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study

BACKGROUND: Dipeptidyl-peptidase-4 inhibitors (DPP4Is) are drugs for the treatment of type 2 diabetes mellitus (T2DM). There is increasing evidence that DPP4Is may result in suppression of the immune system and may increase the risk of infections such as pneumonia. Aim of this study was to evaluate...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Wvan der Zanden, Rogier, de Vries, Frank, Lalmohamed, Arief, Driessen, Johanna H. M., de Boer, Anthonius, Rohde, Gernot, Neef, Cees, den Heijer, Casper
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607497/
https://ncbi.nlm.nih.gov/pubmed/26468883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0139367
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk